|
Mutation Information
|
Mutation Site
|
E138Q |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
NNRTIs |
Literature Information
|
PubMed PMID
|
30277466
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2019 |
|
Journal
|
Antiviral therapy |
|
Title
|
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients. |
|
Author
|
Ciccullo A,Baldin G,Capetti A,Rusconi S,Sterrantino G,d'Ettorre G,Colafigli M,Modica S,Lagi F,Giacomelli A,Cossu MV,Restelli S,De Luca A,Di Giambenedetto S |
|
Evidence
|
In the RPV group, during 371.0 PYFU, there were 5 VF (1 developed non-nucleoside reverse transcriptase inhibitor mutations Y181C and E138Q) and 13 TD.
|
|
|
HIV Mutation Detail Information